Stem Cells--Emerging Markets and Growth Opportunities (Technical Insights)

Frost & Sullivan
May 6, 2004
SKU: MC1000492
License type:
Stem Cells--Emerging Markets and Growth Opportunities (Technical Insights)

 
Regenerative therapies such as stem cell manipulation are developing treatment procedures for damaged tissues and organ failures. The unique ability of stem cells to divide indefinitely and differentiate into specific cell types allows them to form various tissues of the growing embryo during in vivo regeneration. Researchers are depending upon this discovery to assist in the replacement of damaged tissues and fabrication of viable organs for implantation. One approach to engineering new tissues or organs is to induce stem cells to differentiate into organ-specific cells and then seed them onto a scaffold to create a three-dimensional structure. Computer-aided design and manufacturing technology also creates sophisticated tissue constructs using stem cells, connective tissue, and growth factors. Stem cell therapies are emerging as popular options for bone and cartilage repair and alternatives to existing treatment options such as transplantation, surgical repair, artificial prostheses, and drug therapy. Stem cell therapies, in addition to cost savings, eliminate the difficulties associated with shortage of donor organs.

This research produced by the Technical Insights business unit analyzes the new and emerging technologies that enable stem cell therapeutics to move from the laboratory into the commercial world. It analyzes innovative tools and technologies developed by researchers at successful companies, including small startups. It also analyzes major technology drivers and challenges. The research service is designed to help participants identify potential collaborators, stay ahead of the competition, and stay shoulder-to-shoulder with critical developments.